Monika Lamprecht

High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study)

Kristina Fritsch, Benjamin Kasenda, Elisabeth Schorb et al. · Leukemia · 2016 · 183 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

High-dose chemotherapy with autologous haemopoietic stem cell transplantation for newly diagnosed primary CNS lymphoma: a prospective, single-arm, phase 2 trial

Gerald Illerhaus, Benjamin Kasenda, Gabriele Ihorst et al. · The Lancet Haematology · 2016 · 169 citations

Medicine, Hematology, Oncology +15

Early relapses in primary CNS lymphoma after response to polychemotherapy without intraventricular treatment: results of a phase II study

Hendrik Pels, A. Juergens, Axel Glasmacher et al. · Journal of Neuro-Oncology · 2008 · 107 citations

Medicine, Neurology, Oncology +11

High-dose chemotherapy with autologous haematopoietic stem cell support for relapsed or refractory primary CNS lymphoma: a prospective multicentre trial by the German Cooperative PCNSL study group

Benjamin Kasenda, Gabriele Ihorst, Roland Schroers et al. · Leukemia · 2017 · 93 citations

Medicine, Hematology, Oncology +17

Associations of High‐Dose Melphalan Pharmacokinetics and Outcomes in the Setting of a Randomized Cryotherapy Trial

YK Cho, DW Sborov, Monika Lamprecht et al. · Clinical Pharmacology & Therapeutics · 2017 · 37 citations · Full text

Pharmacy, Oncology, Pharmacokinetics +17